Pralsetinib - Blueprint Medicines
At a glance
- Drug Originator Blueprint Medicines
- Drug Licenced by Allist Pharmaceuticals; CStone Pharmaceuticals; Rigel Pharmaceuticals
- Drug Class Amides; Amines; Antineoplastics; Cyclohexanes; Ethers; Fluorinated hydrocarbons; Pyrazoles; Pyridines; Pyrimidines; Small molecules
- Mechanism of Action Proto-oncogene protein c-ret inhibitors
- USA Patent Applicants RIGEL PHARMS
- USA Patents 6
- NDAs 1
- International Patents 80
- Patent Applications 39
 
    Disclaimer
